DOCSLIB.ORG

Roles of Gangliosides in Hypothalamic Control of Energy Balance: New Insights

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

International Journal of Molecular Sciences Review Roles of Gangliosides in Hypothalamic Control of Energy Balance: New Insights Kei-ichiro Inamori * and Jin-ichi Inokuchi * Division of Glycopathology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi 981-8558, Japan * Correspondence: [email protected] (K.-i.I.); [email protected] (J.-i.I.); Tel.: +81-22-727-0116 (K.-i.I.); +81-22-727-0117 (J.-i.I.) Received: 3 July 2020; Accepted: 26 July 2020; Published: 28 July 2020 Abstract: Gangliosides are essential components of cell membranes and are involved in a variety of physiological processes, including cell growth, differentiation, and receptor-mediated signal transduction. They regulate functions of proteins in membrane microdomains, notably receptor tyrosine kinases such as insulin receptor (InsR) and epidermal growth factor receptor (EGFR), through lateral association. Studies during the past two decades using knockout (KO) or pharmacologically inhibited cells, or KO mouse models for glucosylceramide synthase (GCS; Ugcg), GM3 synthase (GM3S; St3gal5), and GD3 synthase (GD3S; St8sia1) have revealed essential roles of gangliosides in hypothalamic control of energy balance. The a-series gangliosides GM1 and GD1a interact with leptin receptor (LepR) and promote LepR signaling through activation of the JAK2/STAT3 pathway. Studies of GM3S KO cells have shown that the extracellular signal-regulated kinase (ERK) pathway, downstream of the LepR signaling pathway, is also modulated by gangliosides. Recent studies have revealed crosstalk between the LepR signaling pathway and other receptor signaling pathways (e.g., InsR and EGFR pathways). Gangliosides thus have the ability to modulate the effects of leptin by regulating functions of such receptors, and by direct interaction with LepR to control signaling. Keywords: ganglioside; glycosphingolipid; leptin receptor signaling; hypothalamic neurons; energy homeostasis 1. Introduction Gangliosides (glycosphingolipids (GSLs) that contain one or more sialic acids) are essential components of membrane microdomains, and play key roles in a variety of important biological processes, including cell growth, differentiation, and signal transduction [1]. Ganglioside synthesis is initiated by addition of a glucose residue to the common precursor ceramide to form glucosylceramide (GlcCer) in the Golgi. Subsequently, a galactose residue is added to GlcCer to form lactosylceramide (LacCer), the precursor for synthesis of various ganglioside species and other types of GSLs (Figure1). GM3 synthase (GM3S, encoded by St3gal5) is a sialyltransferase that transfers sialic acid residue to LacCer via α2,3-linkage to form GM3 ganglioside. Based on GM3, GD3 synthase (GD3S, encoded by St8sia1) transfers sialic acid via α2,8-linkage to form the disialoganglioside GD3, and GM2 synthase (GM2S, encoded by B4galnt1) transfers N-acetylgalactosamine (GalNAc) to form GM2 (Figure1). GM2S can also act on LacCer and GD3 to generate GA2 and GD2, respectively. Gangliosides are involved in functioning of numerous growth factor receptors and hormone receptors, including epidermal growth factor receptor (EGFR), platelet-derived growth factor receptor (PDGFR), vascular endothelial growth factor receptor (VEGFR), hepatocyte growth factor receptor (c-Met), nerve growth factor receptor (TrkA), insulin receptor (InsR), and insulin-like growth factor 1 receptor (IGF1R) [2]. Recent studies Int. J. Mol. Sci. 2020, 21, 5349; doi:10.3390/ijms21155349 www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2020, 21, 5349 2 of 17 Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 2 of 17 have demonstrated the essential roles of gangliosides in hypothalamic control of feeding and energy homeostasishypothalamic through control regulation of feeding of and leptin energy receptor homeostasis (LepR) through signaling. regulation of leptin receptor (LepR) signaling. FigureFigure 1. Biosynthetic 1. Biosynthetic pathway pathway of of ganglio-series ganglio-series gangliosides.gangliosides. GCS GCS (Ugcg (Ugcg), ),a glucosyltransferase, a glucosyltransferase, catalyzescatalyzes the the first first step step in synthesisin synthesis of of ganglio-series ganglio-series gangliosides. Subsequently, Subsequently, LacCerS LacCerS (B4galt5/6 (B4galt5) /6) adds a galactose residue onto GlcCer to form LacCer. GM3S (St3gal5) is a sialyltransferase required adds a galactose residue onto GlcCer to form LacCer. GM3S (St3gal5) is a sialyltransferase required for for initiation of synthesis of a- and b-series gangliosides. GD3S (St8sia1) is a sialyltransferase required initiation of synthesis of a- and b-series gangliosides. GD3S (St8sia1) is a sialyltransferase required for for synthesis of b-series gangliosides. Four species (GM1, GD1a, GD1b, GT1b) comprise the majority synthesis of b-series gangliosides. Four species (GM1, GD1a, GD1b, GT1b) comprise the majority of of total brain gangliosides in mammals. total brain gangliosides in mammals. 2. Leptin Receptor Signaling 2. Leptin Receptor Signaling Leptin, a 16-kDa peptide hormone produced mainly from adipose tissue, is essential for Leptin, a 16-kDa peptide hormone produced mainly from adipose tissue, is essential for maintenance of energy homeostasis and body weight [3]. Adiposity is strongly correlated with maintenancecirculating of leptin energy level. homeostasis Leptin acts as and a transm bodyitter weight of metabolic [3]. Adiposity information is strongly to the hypothalamus, correlated with circulatingwhich plays leptin critical level. roles Leptin in regulation acts as a of transmitter feeding, body of metabolicweight, and information energy expenditure to the hypothalamus, [4]. Several whichhypothalamic plays critical nuclei, roles inincluding regulation the of arcuate feeding, nu bodycleus weight, (ARC), andparaventricular energy expenditure nucleus [4(PVN),]. Several hypothalamicventromedial nuclei, hypothalamus including the(VMH), arcuate and nucleus lateral (ARC),hypothalamic paraventricular area (LH), nucleus are involved (PVN), in ventromedialcontrol of hypothalamusenergy homeostasis (VMH), [5]. and ARC lateral contains hypothalamic two interconnected area (LH),groups are of neurons involved that in express control long-form of energy homeostasisleptin receptor [5]. ARC (LepRb) contains and is two the interconnectedmain site of leptin groups activity of [6]. neurons The proopiomelanocortin that express long-form (POMC) leptin receptorneurons (LepRb) are satiety-promot and is the maining siteand of tonically leptin activity release [6α].-melanocyte-stimulating The proopiomelanocortin hormone (POMC) (α-MSH; neurons are satiety-promotingprocessed from POMC), and tonicallywhich binds release to melanocortinα-melanocyte-stimulating receptor 4 (MC4R) hormone in PVN and (α-MSH; certain processed other fromhypothalamic POMC), which nuclei, binds and to thereby melanocortin promotes receptor an anor 4ectic (MC4R) effect in and PVN energy and expenditure. certain other The hypothalamic agouti- related peptide (AgRP) neurons are hunger-promoting and release (i) AgRP, which competes with nuclei, and thereby promotes an anorectic effect and energy expenditure. The agouti-related peptide α-MSH for MC4R binding in a coordinated fashion to regulate feeding and energy balance, and (ii) (AgRP) neurons are hunger-promoting and release (i) AgRP, which competes with α-MSH for MC4R neuropeptide Y (NPY) and γ-aminobutyric acid (GABA) for regulation of energy balance. LepRb is bindingexpressed in acoordinated in both the above fashion groups to of regulate neurons. feeding However, and postprandially energy balance, increased and (ii)circulating neuropeptide leptin Y (NPY)level and stimulatesγ-aminobutyric POMC acidneurons (GABA) (with forconsequent regulation α-MSH of energy release balance. and inhibition LepRb is of expressed feeding) inbut both the aboveinhibits groups AgRP ofneurons. neurons. Elevated However, leptin postprandially level typically increasedgenerates a circulating strong signal leptin that levelfunctions stimulates to POMCprevent neurons obesity, (with however, consequent such αeffect-MSH is releaseweak or and disrupted inhibition in already-obese of feeding) but subjects. inhibits Obese AgRP rodents neurons. Elevatedand humans leptin level display typically hyperleptinemia generates aand strong do signalnot respond that functions substantially to prevent to exogenous obesity, leptin however, suchadministration effect is weak [7,8]. or disrupted in already-obese subjects. Obese rodents and humans display hyperleptinemia and do not respond substantially to exogenous leptin administration [7,8]. Int. J. Mol. Sci. 2020, 21, 5349 3 of 17 Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 3 of 17 Signaling from leptin is generated via binding to its receptor LepR, a transmembrane protein Signaling from leptin is generated via binding to its receptor LepR, a transmembrane protein belonging to the class I cytokine receptor family [6]. Mice that lack functional leptin or LepR (ob/ob, db/db) belonging to the class I cytokine receptor family [6]. Mice that lack functional leptin or LepR (ob/ob, are hyperphagic and display severe obesity with hyperglycemia and insulin resistance [9]. Six LepR db/db) are hyperphagic and display severe obesity with hyperglycemia and insulin resistance [9]. Six isoforms (termed LepRa through LepRf) present in mice are generated from a single LepR gene by LepR isoforms (termed LepRa through LepRf) present in mice are generated
Recommended publications
  • Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model

    Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model

    Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 T + is online at: average * The Journal of Immunology , 34 of which you can access for free at: 2016; 197:1477-1488; Prepublished online 1 July from submission to initial decision 4 weeks from acceptance to publication 2016; doi: 10.4049/jimmunol.1600589 http://www.jimmunol.org/content/197/4/1477 Molecular Profile of Tumor-Specific CD8 Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A. Waugh, Sonia M. Leach, Brandon L. Moore, Tullia C. Bruno, Jonathan D. Buhrman and Jill E. Slansky J Immunol cites 95 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html http://www.jimmunol.org/content/suppl/2016/07/01/jimmunol.160058 9.DCSupplemental This article http://www.jimmunol.org/content/197/4/1477.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2016 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model Katherine A.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • 743914V1.Full.Pdf

    743914V1.Full.Pdf

    bioRxiv preprint doi: https://doi.org/10.1101/743914; this version posted August 24, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Cross-talks of glycosylphosphatidylinositol biosynthesis with glycosphingolipid biosynthesis 2 and ER-associated degradation 3 4 Yicheng Wang1,2, Yusuke Maeda1, Yishi Liu3, Yoko Takada2, Akinori Ninomiya1, Tetsuya 5 Hirata1,2,4, Morihisa Fujita3, Yoshiko Murakami1,2, Taroh Kinoshita1,2,* 6 7 1Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan 8 2WPI Immunology Frontier Research Center, Osaka University, Suita, Osaka 565-0871, 9 Japan 10 3Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, 11 School of Biotechnology, Jiangnan University, Wuxi, Jiangsu 214122, China 12 4Current address: Center for Highly Advanced Integration of Nano and Life Sciences (G- 13 CHAIN), Gifu University, 1-1 Yanagido, Gifu-City, Gifu 501-1193, Japan 14 15 *Correspondence and requests for materials should be addressed to T.K. (email: 16 [email protected]) 17 18 19 Glycosylphosphatidylinositol (GPI)-anchored proteins and glycosphingolipids interact with 20 each other in the mammalian plasma membranes, forming dynamic microdomains. How their 21 interaction starts in the cells has been unclear. Here, based on a genome-wide CRISPR-Cas9 22 genetic screen for genes required for GPI side-chain modification by galactose in the Golgi 23 apparatus, we report that b1,3-galactosyltransferase 4 (B3GALT4), also called GM1 24 ganglioside synthase, additionally functions in transferring galactose to the N- 25 acetylgalactosamine side-chain of GPI.
  • Congenital Disorders of Glycosylation from a Neurological Perspective

    Congenital Disorders of Glycosylation from a Neurological Perspective

    brain sciences Review Congenital Disorders of Glycosylation from a Neurological Perspective Justyna Paprocka 1,* , Aleksandra Jezela-Stanek 2 , Anna Tylki-Szyma´nska 3 and Stephanie Grunewald 4 1 Department of Pediatric Neurology, Faculty of Medical Science in Katowice, Medical University of Silesia, 40-752 Katowice, Poland 2 Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland; [email protected] 3 Department of Pediatrics, Nutrition and Metabolic Diseases, The Children’s Memorial Health Institute, W 04-730 Warsaw, Poland; [email protected] 4 NIHR Biomedical Research Center (BRC), Metabolic Unit, Great Ormond Street Hospital and Institute of Child Health, University College London, London SE1 9RT, UK; [email protected] * Correspondence: [email protected]; Tel.: +48-606-415-888 Abstract: Most plasma proteins, cell membrane proteins and other proteins are glycoproteins with sugar chains attached to the polypeptide-glycans. Glycosylation is the main element of the post- translational transformation of most human proteins. Since glycosylation processes are necessary for many different biological processes, patients present a diverse spectrum of phenotypes and severity of symptoms. The most frequently observed neurological symptoms in congenital disorders of glycosylation (CDG) are: epilepsy, intellectual disability, myopathies, neuropathies and stroke-like episodes. Epilepsy is seen in many CDG subtypes and particularly present in the case of mutations
  • A Novel Frameshift Pathogenic Variant in ST3GAL5 Causing Salt

    A Novel Frameshift Pathogenic Variant in ST3GAL5 Causing Salt

    www.nature.com/hgv DATA REPORT OPEN A novel frameshift pathogenic variant in ST3GAL5 causing salt and pepper developmental regression syndrome (SPDRS): A case report 1,2 3 2,3 4 fi4 4 Jamal Manoochehri , Seyed Alireza Dastgheib , Hossein Jafari Khamirani , Maryam Mollaie , Zahra Shari , Sina Zoghi✉ , Seyed Mohammad Bagher Tabei3,5, Sanaz Mohammadi2, Fatemeh Dehghanian2, Zahra Farbod2 and Mehdi Dianatpour3,6 © The Author(s) 2021 GM3 synthase deficiency is associated with salt and pepper developmental regression syndrome (SPDRS), a rare genetic disorder. Herein, we report the first Iranian patient with SPDRS. We detected a novel pathogenic variant of ST3GAL5 (NM_003896.4: c.1030_1031del, p.Ile344Cysfs*11). The proband had intellectual disability (ID), failure to thrive, cerebral atrophy, microcephaly, and atonic seizures. The main future challenge proceeding from the results of this study is the prenatal detection of the newly discovered variant; the next step would involve further studies to elucidate the phenotypic spectrum of SPDRS and detect new variants that could cause symptoms ranging from mild to severe. Human Genome Variation; https://doi.org/10.1038/s41439-021-00164-8 GM3 synthase is the first enzyme involved in the biosynthesis of a- occurrence of a set of complications and poor adherence by the and b-series gangliosides. Pathogenic variants in ST3GAL5 that family. Afterward, the dietary interventions were resumed. result in a complete lack of GM3 activity lead to the elimination of The first symptoms were recorded during the first 2 months of all of its downstream biosynthesis products. SPDRS, a rare life, primarily comprising irritability, poor feeding, and failure to neurological disorder caused by GM3 synthase deficiency, leads thrive.
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD

    Supplementary Table S4. FGA Co-Expressed Gene List in LUAD

    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
  • Cholesterol-Dependent Increases in Glucosylceramide

    Cholesterol-Dependent Increases in Glucosylceramide

    Neuropharmacology 110 (2016) 458e469 Contents lists available at ScienceDirect Neuropharmacology journal homepage: www.elsevier.com/locate/neuropharm Cholesterol-dependent increases in glucosylceramide synthase activity in Niemann-Pick disease type C model cells: Abnormal trafficking of endogenously formed ceramide metabolites by inhibition of the enzyme Naohiro Hashimoto 1, Ikiru Matsumoto 1, Hiromasa Takahashi, Hitomi Ashikawa, * Hiroyuki Nakamura , Toshihiko Murayama Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba 260-8675, Japan article info abstract Article history: Sphingolipids such as sphingomyelin and glycosphingolipids (GSLs) derived from glucosylceramide Received 1 February 2016 (GlcCer), in addition to cholesterol, accumulate in cells/neurons in Niemann-Pick disease type C (NPC). Received in revised form The activities of acid sphingomyelinase and lysosomal glucocerebrosidase (GCase), which degrade 10 August 2016 sphingomyelin and GlcCer, respectively, are down-regulated in NPC cells, however, changes in GlcCer Accepted 12 August 2016 synthase activity have not yet been elucidated. We herein demonstrated for the first time that GlcCer Available online 15 August 2016 synthase activity for the fluorescent ceramide, 4-nitrobenzo-2-oxa-1,3-diazole-labeled C6-ceramide À À (NBD-ceramide) increased in intact NPC1( / ) cells and cell lysates without affecting the protein levels. Keywords: (À/À) fl Niemann-Pick disease type C In NBD-ceramide-labeled NPC1 cells, NBD- uorescence preferentially accumulated in the Golgi Cholesterol complex and vesicular specks in the cytoplasm 40 and 150 min, respectively, after labeling, while a Glucosylceramide synthase treatment for 48 h with the GlcCer synthase inhibitors, N-butyldeoxynojirimycin (NB-DNJ) and 1-phenyl- Sphingomyelin 2-palmitoylamino-3-morpholino-1-propanol, accelerated the appearance of vesicular specks emitting À À Vesicular trafficking NBD-fluorescence within 40 min.
  • Supplementary Methods

    Supplementary Methods

    Supplementary methods Human lung tissues and tissue microarray (TMA) All human tissues were obtained from the Lung Cancer Specialized Program of Research Excellence (SPORE) Tissue Bank at the M.D. Anderson Cancer Center (Houston, TX). A collection of 26 lung adenocarcinomas and 24 non-tumoral paired tissues were snap-frozen and preserved in liquid nitrogen for total RNA extraction. For each tissue sample, the percentage of malignant tissue was calculated and the cellular composition of specimens was determined by histological examination (I.I.W.) following Hematoxylin-Eosin (H&E) staining. All malignant samples retained contained more than 50% tumor cells. Specimens resected from NSCLC stages I-IV patients who had no prior chemotherapy or radiotherapy were used for TMA analysis by immunohistochemistry. Patients who had smoked at least 100 cigarettes in their lifetime were defined as smokers. Samples were fixed in formalin, embedded in paraffin, stained with H&E, and reviewed by an experienced pathologist (I.I.W.). The 413 tissue specimens collected from 283 patients included 62 normal bronchial epithelia, 61 bronchial hyperplasias (Hyp), 15 squamous metaplasias (SqM), 9 squamous dysplasias (Dys), 26 carcinomas in situ (CIS), as well as 98 squamous cell carcinomas (SCC) and 141 adenocarcinomas. Normal bronchial epithelia, hyperplasia, squamous metaplasia, dysplasia, CIS, and SCC were considered to represent different steps in the development of SCCs. All tumors and lesions were classified according to the World Health Organization (WHO) 2004 criteria. The TMAs were prepared with a manual tissue arrayer (Advanced Tissue Arrayer ATA100, Chemicon International, Temecula, CA) using 1-mm-diameter cores in triplicate for tumors and 1.5 to 2-mm cores for normal epithelial and premalignant lesions.
  • GM3 Synthase Deficiency

    GM3 Synthase Deficiency

    GM3 synthase deficiency Description GM3 synthase deficiency is characterized by recurrent seizures (epilepsy) and problems with brain development. Within the first few weeks after birth, affected infants become irritable and develop feeding difficulties and vomiting that prevent them from growing and gaining weight at the usual rate. Seizures begin within the first year of life and worsen over time. Multiple types of seizures are possible, including generalized tonic-clonic seizures (also known as grand mal seizures), which cause muscle rigidity, convulsions, and loss of consciousness. Some affected children also experience prolonged episodes of seizure activity called nonconvulsive status epilepticus. The seizures associated with GM3 synthase deficiency tend to be resistant (refractory) to treatment with antiseizure medications. GM3 synthase deficiency profoundly disrupts brain development. Most affected children have severe intellectual disability and do not develop skills such as reaching for objects, speaking, sitting without support, or walking. Some have involuntary twisting or jerking movements of the arms that are described as choreoathetoid. Although affected infants can likely see and hear at birth, vision and hearing become impaired as the disease worsens. It is unknown how long people with GM3 synthase deficiency usually survive. Some affected individuals have changes in skin coloring (pigmentation), including dark freckle-like spots on the arms and legs and light patches on the arms, legs, and face. These changes appear in childhood and may become more or less apparent over time. The skin changes do not cause any symptoms, but they can help doctors diagnose GM3 synthase deficiency in children who also have seizures and delayed development.
  • Integration of Lipidomics and Transcriptomics Data Towards A

    Integration of Lipidomics and Transcriptomics Data Towards A

    Gupta et al. BMC Systems Biology 2011, 5:26 http://www.biomedcentral.com/1752-0509/5/26 RESEARCHARTICLE Open Access Integration of lipidomics and transcriptomics data towards a systems biology model of sphingolipid metabolism Shakti Gupta1, Mano R Maurya1, Alfred H Merrill Jr2, Christopher K Glass3, Shankar Subramaniam1,3,4* Abstract Background: Sphingolipids play important roles in cell structure and function as well as in the pathophysiology of many diseases. Many of the intermediates of sphingolipid biosynthesis are highly bioactive and sometimes have antagonistic activities, for example, ceramide promotes apoptosis whereas sphingosine-1-phosphate can inhibit apoptosis and induce cell growth; therefore, quantification of the metabolites and modeling of the sphingolipid network is imperative for an understanding of sphingolipid biology. Results: In this direction, the LIPID MAPS Consortium is developing methods to quantitate the sphingolipid metabolites in mammalian cells and is investigating their application to studies of the activation of the RAW264.7 macrophage cell by a chemically defined endotoxin, Kdo2-Lipid A. Herein, we describe a model for the C16-branch of sphingolipid metabolism (i.e., for ceramides with palmitate as the N-acyl-linked fatty acid, which is selected because it is a major subspecies for all categories of complex sphingolipids in RAW264.7 cells) integrating lipidomics and transcriptomics data and using a two-step matrix-based approach to estimate the rate constants from experimental data. The rate constants obtained from the first step are further refined using generalized constrained nonlinear optimization. The resulting model fits the experimental data for all species. The robustness of the model is validated through parametric sensitivity analysis.
  • Bovine NK-Lysin: Copy Number Variation and PNAS PLUS Functional Diversification

    Bovine NK-Lysin: Copy Number Variation and PNAS PLUS Functional Diversification

    Bovine NK-lysin: Copy number variation and PNAS PLUS functional diversification Junfeng Chena, John Huddlestonb,c, Reuben M. Buckleyd, Maika Maligb, Sara D. Lawhona, Loren C. Skowe, Mi Ok Leea, Evan E. Eichlerb,c, Leif Anderssone,f,g, and James E. Womacka,1 aDepartment of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843; bDepartment of Genome Sciences, University of Washington, Seattle, WA 98195; cHoward Hughes Medical Institute, University of Washington, Seattle, WA 98195; dSchool of Biological Sciences, University of Adelaide, Adelaide 5005, Australia; eDepartment of Veterinary Integrative Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843; fDepartment of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, SE 75123, Sweden; and gDepartment of Animal Breeding and Genetics, Swedish University of Agricultural Sciences, Uppsala, SE 75007, Sweden Contributed by James E. Womack, November 20, 2015 (sent for review November 5, 2015; reviewed by Denis M. Larkin and Harris A. Lewin) NK-lysin is an antimicrobial peptide and effector protein in the host compared with humans and mice. These include genes coding innate immune system. It is coded by a single gene in humans and AMPs such as the cathelicidins and β-defensins, members of most other mammalian species. In this study, we provide evidence the IFN gene family, C-type lysozyme, and lipopolysaccharide- for the existence of four NK-lysin genes in a repetitive region on binding protein (ULBP) (23–28). Expansion of these gene fam- cattle chromosome 11. The NK2A, NK2B,andNK2C genes are tan- ilies potentially can give rise to new functional paralogs with demly arrayed as three copies in ∼30–35-kb segments, located implications in the unique gastric physiology of ruminants or in 41.8 kb upstream of NK1.
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation

    Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation

    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in